Search research articles
Contact Us
Filters
Showing results (31-40 of 171) with videos related to
Page
of 18
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 5, 2021
Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials
Thibault Mura, Nicola Coley, Hélène Amieva, et al.
Rapid Communications in Mass Spectrometry : RCM
|
September 29, 2015
Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism
Sylvain Lehmann, Jérôme Vialaret, Guillaume Gras Combe, et al.
Journal of Immunological Methods
|
July 29, 2008
Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid
Stéphane Roche, Yves Dauvilliers, Laurent Tiers, et al.
Journal of Alzheimer'S Disease : JAD
|
July 25, 2018
Alzheimer's Disease: Advances in Drug Development
Morgane Piton, Christophe Hirtz, Caroline Desmetz, et al.
Alzheimer'S Research & Therapy
|
March 19, 2020
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
Nicolas R Barthélemy, Randall J Bateman, Christophe Hirtz, et al.
Neurobiology of Aging
|
February 26, 2017
Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process
Audrey Gabelle, Isabelle Jaussent, Christophe Hirtz, et al.
Clinical Chemistry and Laboratory Medicine
|
October 24, 2013
Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid
Constance Delaby, Audrey Gabelle, Philippe Meynier, et al.
Plos Pathogens
|
August 13, 2013
Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases
Aroa Relaño-Ginès, Audrey Gabelle, Claire Hamela, et al.
Journal of Neurology
|
May 12, 2012
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria
Dimitri Renard, Giovanni Castelnovo, Anne Wacongne, et al.
Journal of the American Geriatrics Society
|
January 8, 2021
Five-Year Lower Extremity Function is Associated with White Matter Abnormality in Older Adults
Lingxiao He, Philipe de Souto Barreto, Kelly Virecoulon Giudici, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 171) with videos related to
Sort By:
Page
of 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 5, 2021
Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials
Thibault Mura, Nicola Coley, Hélène Amieva, et al.
Rapid Communications in Mass Spectrometry : RCM
|
September 29, 2015
Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism
Sylvain Lehmann, Jérôme Vialaret, Guillaume Gras Combe, et al.
Journal of Immunological Methods
|
July 29, 2008
Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid
Stéphane Roche, Yves Dauvilliers, Laurent Tiers, et al.
Journal of Alzheimer'S Disease : JAD
|
July 25, 2018
Alzheimer's Disease: Advances in Drug Development
Morgane Piton, Christophe Hirtz, Caroline Desmetz, et al.
Alzheimer'S Research & Therapy
|
March 19, 2020
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
Nicolas R Barthélemy, Randall J Bateman, Christophe Hirtz, et al.
Neurobiology of Aging
|
February 26, 2017
Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process
Audrey Gabelle, Isabelle Jaussent, Christophe Hirtz, et al.
Clinical Chemistry and Laboratory Medicine
|
October 24, 2013
Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid
Constance Delaby, Audrey Gabelle, Philippe Meynier, et al.
Plos Pathogens
|
August 13, 2013
Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases
Aroa Relaño-Ginès, Audrey Gabelle, Claire Hamela, et al.
Journal of Neurology
|
May 12, 2012
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria
Dimitri Renard, Giovanni Castelnovo, Anne Wacongne, et al.
Journal of the American Geriatrics Society
|
January 8, 2021
Five-Year Lower Extremity Function is Associated with White Matter Abnormality in Older Adults
Lingxiao He, Philipe de Souto Barreto, Kelly Virecoulon Giudici, et al.
Page
of 18